Overview

An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to document the clinical effects of bupropion and citalopram in a single subject with Friedreich Ataxia.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
Bupropion
Citalopram
Dexetimide
Criteria
Inclusion Criteria:

- Friedreich Ataxia

Exclusion Criteria:

- Unable to provide Informed Consent